Lumos Pharma Inc (LUMO)
2.286
+0.03
(+1.55%)
USD |
NASDAQ |
Jun 28, 16:00
2.25
-0.04
(-1.57%)
After-Hours: 20:00
Lumos Pharma Cash from Operations (Quarterly): -12.89M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -12.89M |
| December 31, 2023 | -7.393M |
| September 30, 2023 | -7.82M |
| June 30, 2023 | -6.685M |
| March 31, 2023 | -9.197M |
| December 31, 2022 | -5.826M |
| September 30, 2022 | -5.519M |
| June 30, 2022 | -7.245M |
| March 31, 2022 | -8.033M |
| December 31, 2021 | -5.811M |
| September 30, 2021 | -7.046M |
| June 30, 2021 | -6.379M |
| March 31, 2021 | -10.41M |
| December 31, 2020 | -6.98M |
| September 30, 2020 | 0.393M |
| June 30, 2020 | -13.10M |
| March 31, 2020 | -3.31M |
| December 31, 2019 | -2.733M |
| September 30, 2019 | -1.886M |
| June 30, 2019 | -2.285M |
| March 31, 2019 | -2.186M |
| December 31, 2018 | -1.317M |
| September 30, 2018 | -15.01M |
| June 30, 2018 | -6.936M |
| March 31, 2018 | -14.68M |
| Date | Value |
|---|---|
| December 31, 2017 | -17.21M |
| September 30, 2017 | -7.156M |
| June 30, 2017 | -10.90M |
| March 31, 2017 | -13.01M |
| December 31, 2016 | -17.01M |
| September 30, 2016 | -13.22M |
| June 30, 2016 | -16.21M |
| March 31, 2016 | -19.51M |
| December 31, 2015 | -8.352M |
| September 30, 2015 | -7.024M |
| June 30, 2015 | -6.39M |
| March 31, 2015 | -2.321M |
| December 31, 2014 | 130.68M |
| September 30, 2014 | -8.506M |
| June 30, 2014 | -7.036M |
| March 31, 2014 | -6.067M |
| December 31, 2013 | -8.062M |
| September 30, 2013 | -6.279M |
| June 30, 2013 | -4.854M |
| March 31, 2013 | -6.623M |
| December 31, 2012 | -6.661M |
| September 30, 2012 | -3.361M |
| June 30, 2012 | -4.809M |
| March 31, 2012 | -5.64M |
| December 31, 2011 | -1.619M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-13.10M
Minimum
Jun 2020
0.393M
Maximum
Sep 2020
-6.508M
Average
-6.832M
Median
Cash from Operations (Quarterly) Benchmarks
| icad Inc | -1.18M |
| Perspective Therapeutics Inc | 13.85M |
| Palatin Technologies Inc | -8.607M |
| Bio-Path Holdings Inc | -1.038M |
| PDS Biotechnology Corp | -9.938M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 1.00M |
| Cash from Financing (Quarterly) | -0.005M |
| Free Cash Flow | -34.79M |
| Free Cash Flow Per Share (Quarterly) | -1.591 |
| Free Cash Flow to Equity (Quarterly) | -12.89M |
| Free Cash Flow Yield | -188.0% |